Annexin Pharmaceuticals AB (publ) (STO:ANNX)
Sweden · Delayed Price · Currency is SEK 13.70
-0.15 (-1.08%)
May 21, 2026, 12:14 PM CET
STO:ANNX Market Cap
STO:ANNX has a market cap or net worth of 97.77 million as of May 21, 2026. Its market cap has decreased by -51.88% in one year.
Market Cap
97.77M
Enterprise Value
80.70M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
13.70
Market Cap Chart
Since April 19, 2017, STO:ANNX's market cap has increased from 50.21M to 97.77M, an increase of 94.72%. That is a compound annual growth rate of 7.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 97.77M | -30.05% |
| Dec 30, 2025 | 139.77M | -39.44% |
| Dec 30, 2024 | 230.78M | 161.10% |
| Dec 29, 2023 | 88.39M | -42.68% |
| Dec 30, 2022 | 154.19M | 12.35% |
| Dec 30, 2021 | 137.24M | 9.62% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 19, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alligator Bioscience AB | 141.32M |
| Simris Group AB (PUBL) | 134.71M |
| NextCell Pharma AB | 121.86M |
| Magle Chemoswed Holding AB | 118.99M |
| IRLAB Therapeutics AB | 106.00M |
| AcouSort AB | 103.28M |
| Biovica International AB | 102.17M |
| Scandinavian ChemoTech AB | 92.40M |